Lazertinib in pretreated EGFR T790M-mutated advanced non-small cell lung cancer: A real-world multicenter study. Kim H, Ahn BC, Lee J, Lee JB, et al. Lung Cancer 2023;180:107213.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim H, Ahn BC, Lee J, Lee JB, et al. Lazertinib in pretreated EGFR T790M-mutated advanced non-small cell lung cancer: A real-world multicenter study. Lung Cancer 2023;180:107213.
PMID: 37104879